The effect of vaginal cyclogest administration on uterine- fetal vessels resistance in women with preterm labour.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201705133025N7

Enrollment

Registered

2017-06-01

Start date

2016-05-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm labour. Preterm labour without delivery

Interventions

Intervention 1: Intervention group: Cyclogest, one Vaginal Suppository 400 mg in addition to sulfate magnesium. Intervention 2: Control group: Sulfate magnesium.

Prevention

Treatment - Drugs

Intervention group: Cyclogest, one Vaginal Suppository 400 mg in addition to sulfate magnesium

Control group: Sulfate magnesium

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: Singleton pregnant women; 24- 33 weeks; uterine regular conteraction and intact amniotic bag. Exclusion criteria: multiple pregnancy; rupture of amniotic bag during the study; delivery before second sonography; vaginal bleeding; the history of use of progestrone.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Mean PI of uterine- fetal vessels. Timepoint: Before intervention and after 24 houres. Method of measurement: Doppler sonography of uterine- fetal vessels.;Mean RI of uterine- fetal vessels. Timepoint: Before intervention and after 24 houres. Method of measurement: Doppler sonography of uterine- fetal vessels.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Azam Sherafati

Kowsar Hospital

fmovahed@qums.ac.irdrsherafati.gynecologist@gmail.com+98 32236374

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026